141 related articles for article (PubMed ID: 17326278)
21. Long-term visual safety of voriconazole in adult patients with paracoccidioidomycosis.
Laties AM; Fraunfelder FT; Tomaszewski K; Goodrich J; Moreira AT; Sato MT; de Queiroz-Telles F
Clin Ther; 2010 Dec; 32(13):2207-17. PubMed ID: 21316537
[TBL] [Abstract][Full Text] [Related]
22. Adverse neurologic events associated with voriconazole use in 3 cats.
Quimby JM; Hoffman SB; Duke J; Lappin MR
J Vet Intern Med; 2010; 24(3):647-9. PubMed ID: 20384957
[TBL] [Abstract][Full Text] [Related]
23. Voriconazole induced bradycardia.
Uludağ D; Ozdemir N; Tüysüz G; Eroğlu AG; Celkan T
Pediatr Hematol Oncol; 2013 Oct; 30(7):674-6. PubMed ID: 23484777
[TBL] [Abstract][Full Text] [Related]
24. Bullous phototoxicity from voriconazole.
Barbosa NS; Wetter DA
J Emerg Med; 2014 Mar; 46(3):e83-4. PubMed ID: 24412056
[No Abstract] [Full Text] [Related]
25. Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine.
Kato J; Mori T; Nakamura Y; Sakurai M; Aisa Y; Ikeda Y; Okamoto S
Eur J Clin Pharmacol; 2009 Mar; 65(3):323-4. PubMed ID: 19031074
[No Abstract] [Full Text] [Related]
26. Voriconazole: a new triazole antifungal agent.
Johnson LB; Kauffman CA
Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
[TBL] [Abstract][Full Text] [Related]
27. The safety of voriconazole.
Potoski BA; Brown J
Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
[No Abstract] [Full Text] [Related]
28. Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
Alkan Y; Haefeli WE; Burhenne J; Stein J; Yaniv I; Shalit I
Clin Infect Dis; 2004 Sep; 39(6):e49-52. PubMed ID: 15472801
[TBL] [Abstract][Full Text] [Related]
29. Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
Hansford JR; Cole C; Blyth CC; Gottardo NG
J Antimicrob Chemother; 2012 Jul; 67(7):1807-9. PubMed ID: 22454488
[No Abstract] [Full Text] [Related]
30. Voriconazole: skeletal fluorosis.
Prescrire Int; 2013 Jun; 22(139):154. PubMed ID: 23866355
[No Abstract] [Full Text] [Related]
31. Photo quiz. Generalized pain in a 20-year-old man with chronic granulomatous disease.
Launay E; Thomas C; Gras-Le Guen C; Geffroy L; Moreau A; Lortholary O
Clin Infect Dis; 2013 Aug; 57(4):562-3, 616-7. PubMed ID: 23881728
[No Abstract] [Full Text] [Related]
32. [Biliary lithiasis and cholecystitis with voriconazole: about 3 cases].
Gérardin-Marais M; Allain-Veyrac G; Danner I; Jolliet P
Therapie; 2006; 61(4):367-9. PubMed ID: 17124955
[No Abstract] [Full Text] [Related]
33. Safety of voriconazole and dose individualization.
Lutsar I; Hodges MR; Tomaszewski K; Troke PF; Wood ND
Clin Infect Dis; 2003 Apr; 36(8):1087-8. PubMed ID: 12684928
[No Abstract] [Full Text] [Related]
34. Fever and eosinophilia associated with voriconazole.
Vishnubhotla P; Ibrahim RB; Abidi MH; Chandrasekar PH
Ann Pharmacother; 2004 May; 38(5):900-1. PubMed ID: 15039477
[No Abstract] [Full Text] [Related]
35. Voriconazole-induced pseudoporphyria.
Tolland JP; McKeown PP; Corbett JR
Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):29-31. PubMed ID: 17254033
[TBL] [Abstract][Full Text] [Related]
36. Voriconazole-induced retinoid-like photosensitivity in children.
Rubenstein M; Levy ML; Metry D
Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856
[TBL] [Abstract][Full Text] [Related]
37. Clinical images: voriconazole-induced periostitis deformans.
Becce F; Malghem J; Lecouvet FE; Vande Berg BC; Omoumi P
Arthritis Rheum; 2012 Oct; 64(10):3490. PubMed ID: 22777747
[No Abstract] [Full Text] [Related]
38. Pseudoporphyria associated with voriconazole.
Kwong WT; Hsu S
J Drugs Dermatol; 2007 Oct; 6(10):1042-4. PubMed ID: 17966183
[TBL] [Abstract][Full Text] [Related]
39. [Careful: skins cancers and voriconazole].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2011 Nov; 138(11):805-6. PubMed ID: 22078051
[No Abstract] [Full Text] [Related]
40. Voriconazole-induced bradycardia without QT interval prolongation: a possible non-concentration-dependent adverse effect.
Perbet S; Blondonnet R; Guérin R; Cayot-Constantin S; Constantin JM
Intensive Care Med; 2013 Mar; 39(3):531-2. PubMed ID: 23291731
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
